FDA Clearance Tracker · P990004-S039
SURGIFOAM Absorbable Gelatin Sponge, U.S.P.
Last checked: Nov 20, 2026Latest source record: Oct 19, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 19, 2021
Approved
Time to decision
515 days
Received May 22, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990004-S039
- Device name
- SURGIFOAM Absorbable Gelatin Sponge, U.S.P.
- Applicant
- Ferrosan Meidcal Devices A/S
- Applicant location
- Soeborg
- Received
- May 22, 2020
- Decided
- Oct 19, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990004
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
Approval for addition of an alternate sterilization site and a change to the sterilization dosage for SURGIFOAM Absorbable Gelatin Sponge (Oral Sponge and Hemorrhoidectomy Sponge) and SURGIFOAM® Absorbable Gelatin Powder
Source documents
Other decisions for Ferrosan Meidcal Devices A/S
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.